Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00811551 · ClinicalTrials.gov registry record
Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 22
- Enrollment target
NCT00811551: Completed study, sponsored by Abbott Medical Devices.
NCT00811551 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00811551 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
zWedge is a clinical feasibility IDE study. The objective is to characterize the relationship between intra-thoracic impedance measurements obtained from a CRT-D device and pulmonary capillary wedge pressure (PCWP) measured via a right heart catheterization (RHC) acutely and over time.
Interventions
- DEVICE CRT-D (Intra-thoracic Impedance Monitoring)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-04 |
What the finished NCT00811551 record still lists
NCT00811551 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CRT-D (Intra-thoracic Impedance Monitoring) is the first listed.
NCT00811551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00811551 about?
NCT00811551 is a clinical study titled "Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices". zWedge is a clinical feasibility IDE study. The objective is to characterize the relationship between intra-thoracic impedance measurements obtained from a CRT-D device and pulmonary capillary wedge pressure (PCWP) measured via a right heart catheterization (RHC) acutely and over time.
What is the current status of trial NCT00811551?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2008-12. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00811551?
The interventions under investigation include: CRT-D (Intra-thoracic Impedance Monitoring) (DEVICE).
Who is sponsoring clinical trial NCT00811551?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia